WebDrug Dosing Laboratory Monitoring Argatroban Bolus: None Continuous infusion: Normal organ function → 2 μm/kg/min Liver dysfunction (bilirubin > 1.5 mg/ dl) → 0.5–1.2 μm/kg/min Heart failure, anasarca, post-cardiac surgery → 0.5–1.2 μm/kg/min Adjust to APTT 1.5–3.0 times baseline Bivalirudin Bolus: None Continuous infusion: WebNov 27, 2024 · Conditional recommendations include the choice among non-heparin anticoagulants (argatroban, bivalirudin, danaparoid, fondaparinux, direct oral anticoagulants) for treatment of acute HIT. ... rivaroxaban at a dose of 15 mg twice per day for 3 weeks followed by 20 mg once per day is preferred. For patients with acute isolated …
Angiomax (bivalirudin) dosing, indications, interactions, …
Webindication, dose, monitoring. Secondary Objectives: • Frequency and duration of use of bivalirudin • Time to therapeutic aPTT • Services and patient population utilizing bivalirudin • Pharmacist involvement in monitoring. Objectives. Results • Bivalirudin was initiated at an appropriate dose 60% of the time based on the UMMC guideline Web&rs\uljkw 7kh 8qlyhuvlw\ ri 7h[dv 0' $qghuvrq &dqfhu &hqwhu $33(1',; & 1rq khsdulq $qwlfrdjxodqwv 'rvlqj dqg 0rqlwrulqj 'uxj'rvlqj 'rvh $gmxvwphqwv &rqvlghudwlrqv daily pay family dollar
Evaluation of the Appropriateness of Bivalirudin Prescribing …
WebA total of 21 adult patients received bivalirudin with infusion rates ranging from 0.028 to 0.2 mg/kg/h with or without initial bolus doses. 10 This wide variability in dosing … WebApr 6, 2013 · The anticipated 30-day event rates for the composite ischemia end point, major bleeding, and the net clinical outcome end point were 6.5%, 9.0%, and 12.4%, respectively, in the control group; 5.3% ... WebBolus and infusion doses are calculated according to the patient’s weight - See above dosing chart. Reconstituted vial (250 mg/5 mL) may be stored at 2 to 8°C for up to 24 … biolyss isle